Physicians’ perceptions of the factors influencing disclosure of secondary findings in tumour genomic profiling in Japan: a qualitative study
- 16 August 2021
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 30 (1) , 88-94
Abstract
Tumour genomic profiling (TGP), conducted in search of therapeutics, sometimes reveals potentially pathogenic germline variants as secondary findings (SFs). Physicians involved in TGP are often specialised in oncology and not in clinical genetics. To better utilise SFs, we explored issues physicians have during disclosure and the potential for collaborations with clinical genetics professionals. Semi-structured interviews were conducted with 14 physicians who had experience in handling outpatient TGP at designated core hospitals for cancer genomic medicine in Japan. The data were analysed thematically. The difficulties physicians experienced during informed consent (IC) included educating patients about SFs, providing detailed information on SFs, and explaining the impact of SFs on patients’ family members. When SFs were detected, physicians had reservations regarding the relevance of the disclosure criteria. Confirmatory germline tests were performed using peripheral blood when tumour-only tests detected suspected SFs. Some physicians had reservations about the necessity of confirmatory tests when they did not affect the patients’ treatment options. To encourage patients to receive confirmatory tests, improvements are necessary in the healthcare system, such as insurance reimbursements, education for physicians so that they can provide a better explanation to their patients, and genetic literacy of physicians and patients. The physicians offered insights into the challenges they experienced related to IC, disclosure of SFs, and expectations for active collaborations with clinical genetics professionals. Wider healthcare insurance coverage and better genetic literacy of the population may lead to more patients taking confirmatory tests when SFs are suspected.Keywords
Funding Information
- The Japan Ministry of Health, Labour and Welfare
- The Japan Ministry of Health, Labour and Welfare
This publication has 17 references indexed in Scilit:
- Advanced cancer patients’ attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative studyEuropean Journal of Cancer Care, 2016
- Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAJAMA Oncology, 2016
- Standards for Reporting Qualitative ResearchAcademic Medicine, 2014
- Genomic testing in cancer: Patient knowledge, attitudes, and expectationsCancer, 2014
- Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer careEuropean Journal of Human Genetics, 2013
- Genetics specialists’ perspectives on disclosure of genomic incidental findings in the clinical settingPatient Education and Counseling, 2013
- Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling?Genetics in Medicine, 2011
- Women's Experience of Telehealth Cancer Genetic CounselingJournal of Genetic Counseling, 2010
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- Telegenetics in Maine: Successful clinical and educational service delivery model developed from a 3-year pilot projectGenetics in Medicine, 2005